Rallybio Corporation to Present at the 4th Annual Evercore ISI HealthCONx Conference
11/24/2021 - 08:00 AM
NEW HAVEN, Conn. --(BUSINESS WIRE)--
Rallybio Evercore ISI HealthCONx Conference on Wednesday, December 1, 2021 at 8:00 a.m. ET . Rallybio will also host one-on-one meetings on the same day.
A webcast of the presentation will be accessible through the Events and Presentations section of Rallybio’s website at www.rallybio.com . An archived replay of the webcast will be available for 30 days following the presentation.
About Rallybio
Rallybio is a clinical-stage biotechnology company committed to identifying and accelerating the development of life-transforming therapies for patients with severe and rare diseases. Since its launch in January 2018 , Rallybio has built a portfolio of promising product candidates, which are now in development to address rare diseases in the areas of hematology, immuno-inflammation, maternal fetal health, and metabolic disorders. The Company’s mission is being advanced by a team of highly experienced biopharma industry leaders with extensive research, development, and rare disease expertise. Rallybio is headquartered in New Haven, Connecticut , with an additional facility at the University of Connecticut’s Technology Incubation Program in Farmington, Connecticut . For more information, please visit www.rallybio.com
View source version on businesswire.com : https://www.businesswire.com/news/home/20211124005492/en/
Investor Contacts
Steven Tuch
investors@rallybio.com
Hannah Deresiewicz
hannah.deresiewicz@sternir.com
Media Contact
Tara DiMilia
Tara.dimilia@tmstrat.com
Source: Rallybio Corporation
RLYB Rankings
#4864 Ranked by Stock Gains
RLYB Stock Data
Industry
Research and Development in Biotechnology
Sector
Professional, Scientific, and Technical Services
About RLYB
rallybio is a privately-held early-stage biotechnology company incorporated in january 2018. our ambition is to create a world-leading biotechnology organization that transforms the lives of patients with devastating disease, built around people with an outstanding track record in pharmaceutical research and development. we will work on highly-promising drug candidates that have strong biological rationales and that can be addressed using the well-validated therapeutic modalities of small molecules, engineered proteins, and antibodies. rallybio’s founders are seasoned leaders from the biopharma industry with a wide breadth of research, development, and financial experience. the company is based in farmington, ct, at the university of connecticut’s technology incubation program. we are assembling a small team of people with an outstanding track record in pharmaceutical research and development to search for and evaluate assets using a series of robust clinical and commercial filters tha
